STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. BIVI
  4. [EFFECT] BIOVIE INC. SEC Filing

[EFFECT] BIOVIE INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 18, 2025
Accession Number: 0001520138-25-000294
Submission Type: POS AM
CIK: 0001580149
Company Name: BIOVIE INC.
File Number: 333-288525

Source: View Original Filing on SEC EDGAR

Stock BIVI logo
Biovie Inc

NASDAQ:BIVI

BIVI Rankings

#6250 Ranked by Market Cap
N/A Ranked by Dividends

BIVI Latest News

Nov 19, 2025
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
Sep 26, 2025
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
Aug 13, 2025
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes
Aug 11, 2025
BioVie Inc. Announces Closing of $12 Million Public Offering
Aug 7, 2025
BioVie Inc. Announces Pricing of $12 Million Public Offering

BIVI Latest SEC Filings

Nov 13, 2025
[8-K] BIOVIE INC. Reports Material Event
Nov 12, 2025
[8-K] BIOVIE INC. Reports Material Event
Nov 10, 2025
[10-Q] BIOVIE INC. Quarterly Earnings Report
Oct 28, 2025
[Form 3] BIOVIE INC. Initial Statement of Beneficial Ownership
Oct 27, 2025
[Form 3] BIOVIE INC. Initial Statement of Beneficial Ownership

BIVI Stock Data

9.57M
7.29M
3.28%
1.53%
2.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARSON CITY